Complete Filing Data
James Hardie Industries plc reported Payment To Fund of $99.20 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean James Hardie Industries plc did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Revenue * | $2.37B | $2.35B | $2.47B | $2.30B | $1.86B | $1.67B | $1.68B | $1.32B | $1.25B | $1.10B | $1.08B | $987.4M | $902.0M | $830.5M | $775.1M | $708.5M | $813.8M |
| Revenue * | $3.88B | $3.94B | $3.78B | $3.61B | $2.91B | $2.61B | $2.51B | $2.05B | $1.92B | $1.73B | $1.66B | $1.49B | $1.32B | $1.24B | $1.17B | $1.12B | $1.20B |
| Income Tax Expense Benefit | $221.4M | $244.6M | $211.5M | $184.0M | $149.2M | $46.5M | $71.8M | $28.2M | $90.5M | $86.1M | $31.3M | -$44.9M | -$11.8M | -$453.2M | -$443.6M | $66.2M | $19.5M |
| Selling General And Administrative Expense | $596.2M | $602.2M | $494.0M | $461.2M | $389.6M | $415.8M | $403.6M | $311.3M | $291.6M | $254.2M | $245.5M | $224.4M | $218.6M | $191.0M | $173.4M | $185.8M | $208.8M |
| Research And Development Expense | $48.5M | $47.0M | $39.6M | $38.0M | $34.3M | $32.8M | $37.9M | $33.3M | $30.3M | $29.5M | $31.7M | $33.1M | $37.2M | $30.4M | $28.0M | $27.1M | $23.8M |
| Other Nonoperating Income Expense | -$200.0K | $2.7M | $12.8M | -$200.0K | $100.0K | -$100.0K | $100.0K | $700.0K | $1.3M | $2.1M | -$4.9M | $2.6M | $1.8M | $3.0M | -$3.7M | $6.3M | -$14.8M |
| Operating Income Loss | $655.9M | $767.4M | $741.4M | $682.6M | $472.8M | $342.5M | $351.6M | $229.2M | $393.2M | $354.0M | $335.0M | $53.1M | $29.5M | $155.5M | $104.7M | -$21.0M | $173.6M |
| Net Income Loss | $424.0M | $510.2M | $512.0M | $459.1M | $262.8M | $241.5M | $228.8M | $146.1M | $276.5M | $244.4M | $291.3M | $99.5M | $45.5M | $604.3M | -$347.0M | -$84.9M | $136.3M |
| Gross Profit | $1.51B | $1.59B | $1.31B | $1.31B | $1.05B | $933.7M | $831.0M | $730.2M | $674.7M | $632.2M | $578.8M | $506.4M | $419.3M | $407.0M | $391.9M | $416.1M | $388.8M |
| Comprehensive Income Net Of Tax | $434.1M | $495.2M | $480.7M | $443.7M | $318.3M | $209.7M | $199.8M | $147.0M | $273.5M | $245.6M | $257.8M | $85.2M | $43.5M | $598.5M | -$351.0M | -$27.9M | $121.6M |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | $1.6M | -$14.5M | -$33.4M | -$14.7M | $55.9M | -$32.6M | -$28.9M | $900.0K | -$3.0M | $900.0K | -$32.9M | -$15.2M | -$2.9M | -$5.9M | -$6.6M | $56.0M | -$19.8M |
| Other Comprehensive Income Loss Net Of Tax | $10.1M | -$15.0M | -$31.3M | -$15.4M | $55.5M | -$31.8M | -$29.0M | $900.0K | -$3.0M | $1.2M | -$33.5M | -$14.3M | -$2.0M | -$5.8M | -$4.0M | ||
| Deferred Income Taxes And Tax Credits | $62.1M | $34.6M | $48.4M | $49.8M | $85.8M | $64.0M | $12.7M | -$76.8M | $26.0M | -$100.0K | -$37.4M | -$70.7M | -$52.8M | ||||
| Income Taxes Paid Net Including Withholding Taxes | $128.1M | $183.1M | $117.1M | $92.7M | -$3.7M | $52.5M | $26.3M | $49.1M | $51.5M | $57.8M | $35.6M | $11.6M | $83.3M | ||||
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | $412.0M | $288.0M | $300.6M | $174.3M | $367.0M | $330.5M | $322.6M | $54.6M | $33.7M | $151.1M | $96.6M | -$18.7M | $155.8M | ||||
| Interest Expense | $57.5M | $54.2M | $32.9M | $28.5M | $26.6M | $9.8M | $4.5M | $5.5M | $11.2M | $9.0M | $7.7M | $11.2M | |||||
| Accrued Income Taxes Current | $10.3M | $13.0M | $15.4M | $9.5M | $6.6M | $8.9M | $13.4M | $3.2M | $1.9M | $4.8M | $1.8M | $5.4M | $6.0M | $81.7M | $3.9M | $34.9M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2020 |
|---|---|
| Cost of Revenue * | |
| Revenue * | |
| Income Tax Expense Benefit | -$25.5M |
| Selling General And Administrative Expense | |
| Research And Development Expense | |
| Other Nonoperating Income Expense | |
| Operating Income Loss | |
| Net Income Loss | |
| Gross Profit | |
| Comprehensive Income Net Of Tax | |
| Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax | |
| Other Comprehensive Income Loss Net Of Tax | |
| Deferred Income Taxes And Tax Credits | |
| Income Taxes Paid Net Including Withholding Taxes | |
| Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments | |
| Interest Expense | |
| Accrued Income Taxes Current |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 | FY2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $2.16B | $1.86B | $1.61B | $1.33B | $1.06B | $1.04B | $974.4M | -$221.5M | -$212.2M | -$225.2M | -$202.6M | -$199.0M | $18.2M | $126.4M | -$454.5M | -$117.9M | -$108.7M | -$202.6M |
| Cash And Cash Equivalents At Carrying Value | $562.7M | $365.0M | $113.0M | $125.0M | $208.5M | $144.4M | $78.7M | $281.6M | $78.9M | $107.1M | $67.0M | $167.5M | $153.7M | $265.4M | $18.6M | $19.2M | $42.4M | $35.4M |
| Dividends Common Stock Cash | $133.6M | $178.1M | $310.9M | $159.3M | $176.7M | $167.6M | $173.3M | $258.7M | $267.0M | $323.7M | $188.5M | $17.4M | $34.6M | |||||
| Restricted Short Term Investments Asbestos | $175.8M | $178.4M | $140.9M | $119.7M | $26.6M | $21.6M | $110.0M | $120.0M | $100.0M | $100.0K | $7.1M | $6.0M | $5.8M | $13.3M | ||||
| Restricted Cash And Cash Equivalents Asbestos | $37.9M | $45.8M | $67.6M | $141.9M | $104.9M | $36.4M | $39.8M | $26.6M | $108.9M | $17.0M | $22.0M | $60.2M | $126.4M | $59.0M | $56.1M | $44.5M | ||
| Property Plant And Equipment Net | $2.17B | $2.04B | $1.84B | $1.46B | $1.37B | $1.34B | $1.39B | $992.1M | $879.0M | $867.0M | $880.1M | $702.8M | $658.9M | $674.7M | $707.7M | $710.6M | ||
| Workers Compensation Liability Asbestos Current | $2.3M | $1.6M | $1.8M | $3.2M | $1.6M | $1.5M | $2.0M | $2.1M | $2.9M | $4.1M | $4.5M | $4.3M | $900.0K | $500.0K | $300.0K | $100.0K | ||
| Workers Compensation Liabilities Asbestos Noncurrent | $16.5M | $13.6M | $16.4M | $18.6M | $20.3M | $20.7M | $25.8M | $28.8M | $40.4M | $46.8M | $45.5M | $47.6M | $60.7M | $83.4M | $90.4M | $98.8M | ||
| Workers Compensation Assets Asbestos Noncurrent | $16.5M | $13.6M | $16.4M | $18.6M | $20.3M | $20.7M | $25.8M | $28.8M | $40.4M | $46.8M | $45.5M | $47.6M | $60.7M | $83.4M | $90.4M | $98.8M | ||
| Workers Compensation Assets Asbestos Current | $2.3M | $1.6M | $1.8M | $3.2M | $1.6M | $1.5M | $2.0M | $2.1M | $2.9M | $4.1M | $4.5M | $4.3M | $900.0K | $500.0K | $300.0K | $100.0K | ||
| Treasury Stock Value Acquired Cost Method | $149.9M | $300.0M | $200.0M | $99.8M | $22.3M | $9.1M | $22.1M | $19.0M | ||||||||||
| Retained Earnings Accumulated Deficit | $1.73B | $1.45B | $1.20B | $892.4M | $611.4M | $659.5M | $577.1M | -$635.3M | -$612.9M | -$621.8M | -$586.6M | -$602.4M | -$357.6M | -$214.6M | -$784.7M | -$437.7M | ||
| Other Liabilities Noncurrent | $55.5M | $58.5M | $50.1M | $48.9M | $54.8M | $43.7M | $44.6M | $25.9M | $15.9M | $14.7M | $21.0M | $25.7M | $36.8M | $39.7M | $37.6M | $80.6M | ||
| Other Liabilities Current | $60.2M | $26.0M | $41.2M | $29.4M | $32.7M | $12.1M | $9.9M | $12.8M | $11.8M | $11.9M | $7.3M | $20.4M | $26.7M | $19.3M | $53.8M | $27.7M | ||
| Other Assets Noncurrent | $24.8M | $19.3M | $19.9M | $4.1M | $3.4M | $4.7M | $2.9M | $4.7M | $19.6M | $21.5M | $30.8M | $27.7M | $30.4M | $40.8M | $32.6M | $44.7M | ||
| Liabilities Current | $810.2M | $797.7M | $697.3M | $769.9M | $901.1M | $510.0M | $483.0M | $394.6M | $428.8M | $399.8M | $377.9M | $541.3M | $322.9M | $403.1M | $322.5M | $414.1M | ||
| Liabilities And Stockholders Equity | $5.23B | $4.91B | $4.48B | $4.24B | $4.09B | $4.03B | $4.03B | $2.35B | $2.01B | $2.03B | $2.04B | $2.10B | $2.11B | $2.31B | $1.96B | $2.18B | ||
| Liabilities | $3.07B | $3.05B | $2.87B | $2.91B | $3.03B | $2.99B | $3.06B | $2.57B | $2.22B | $2.25B | $2.25B | $2.30B | $2.10B | $2.18B | $2.42B | $2.30B | ||
| Common Stock Value | $222.1M | $224.7M | $230.0M | $232.1M | $231.4M | $230.6M | $230.0M | $229.5M | $229.1M | $231.4M | $231.2M | $230.6M | $227.3M | $224.0M | $222.5M | $221.1M | ||
| Assets Current | $1.70B | $1.43B | $1.08B | $1.12B | $943.6M | $908.4M | $754.1M | $842.6M | $632.1M | $534.3M | $524.0M | $659.1M | $696.6M | $866.4M | $458.1M | $464.5M | ||
| Assets | $5.23B | $4.91B | $4.48B | $4.24B | $4.09B | $4.03B | $4.03B | $2.35B | $2.01B | $2.03B | $2.04B | $2.10B | $2.11B | $2.31B | $1.96B | $2.18B | ||
| Asbestos Fund Liability Non Current | $864.2M | $873.0M | $857.7M | $1.01B | $1.01B | $882.5M | $979.1M | $1.10B | $1.04B | $1.18B | $1.29B | $1.57B | $1.56B | $1.54B | $1.59B | $1.51B | ||
| Asbestos Fund Liability Current | $119.4M | $116.7M | $119.4M | $132.9M | $122.2M | $103.9M | $110.5M | $114.1M | $116.4M | $125.9M | $131.6M | $134.5M | $135.0M | $125.3M | $111.1M | $106.7M | ||
| Additional Paid In Capital Common Stock | $271.9M | $256.5M | $237.9M | $230.4M | $224.6M | $207.3M | $197.6M | $185.6M | $173.8M | $164.4M | $153.2M | $139.7M | $101.1M | $67.6M | $52.5M | $39.5M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$58.2M | -$68.3M | -$53.3M | -$22.0M | -$6.6M | -$62.1M | -$30.3M | -$1.3M | -$2.2M | $800.0K | -$400.0K | $33.1M | $47.4M | $49.4M | $55.2M | $59.2M | ||
| Accounts Payable And Accrued Liabilities Current | $446.4M | $463.3M | $387.7M | $458.0M | $307.0M | $274.7M | $255.5M | $193.3M | $173.5M | $127.2M | $149.6M | $142.0M | $103.7M | $92.6M | $106.4M | $100.9M | ||
| Allowance For Doubtful Accounts Receivable Current | $2.9M | $1.3M | $900.0K | $1.1M | $800.0K | $1.0M | $2.1M | $2.3M | $2.7M | $2.3M | ||||||||
| Prepaid Expense And Other Assets Current | $100.6M | $68.2M | $41.0M | $43.2M | $38.9M | $26.1M | $31.3M | $25.4M | $28.3M | $18.1M | $24.3M | $32.0M | $19.2M | $18.8M | $31.6M | |||
| Inventory Net | $347.1M | $337.8M | $344.2M | $279.7M | $218.3M | $305.1M | $317.4M | $255.7M | $202.9M | $193.0M | $218.0M | $186.5M | $172.1M | $179.8M | $161.5M | $149.1M | ||
| Insurance Receivable Asbestos Current | $5.5M | $5.1M | $6.8M | $7.9M | $6.6M | $5.0M | $7.5M | $5.1M | $5.7M | $16.7M | $16.7M | $28.0M | $22.2M | $19.9M | $13.7M | |||
| Employee Related Liabilities Current | $133.3M | $143.3M | $108.3M | $116.6M | $112.5M | $87.1M | $84.9M | $61.8M | $60.5M | $63.0M | $60.6M | $55.4M | $44.0M | $45.4M | $40.9M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $605.6M | $415.8M | $185.6M | $271.9M | $318.4M | $185.8M | $123.6M | $313.2M | $192.8M | $129.1M | ||||||||
| Accounts And Other Receivables Net Current | $391.8M | $366.1M | $354.8M | $398.4M | $333.2M | $363.3M | $254.6M | $202.7M | $199.5M | $173.3M | $133.3M | $139.2M | $149.0M | $137.7M | $138.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2015 | Q2 2014 |
|---|---|---|
| Stockholders Equity | ||
| Cash And Cash Equivalents At Carrying Value | ||
| Dividends Common Stock Cash | ||
| Restricted Short Term Investments Asbestos | ||
| Restricted Cash And Cash Equivalents Asbestos | ||
| Property Plant And Equipment Net | ||
| Workers Compensation Liability Asbestos Current | ||
| Workers Compensation Liabilities Asbestos Noncurrent | ||
| Workers Compensation Assets Asbestos Noncurrent | ||
| Workers Compensation Assets Asbestos Current | ||
| Treasury Stock Value Acquired Cost Method | $22.3M | $9.8M |
| Retained Earnings Accumulated Deficit | ||
| Other Liabilities Noncurrent | ||
| Other Liabilities Current | ||
| Other Assets Noncurrent | ||
| Liabilities Current | ||
| Liabilities And Stockholders Equity | ||
| Liabilities | ||
| Common Stock Value | ||
| Assets Current | ||
| Assets | ||
| Asbestos Fund Liability Non Current | ||
| Asbestos Fund Liability Current | ||
| Additional Paid In Capital Common Stock | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | ||
| Accounts Payable And Accrued Liabilities Current | ||
| Allowance For Doubtful Accounts Receivable Current | ||
| Prepaid Expense And Other Assets Current | ||
| Inventory Net | ||
| Insurance Receivable Asbestos Current | ||
| Employee Related Liabilities Current | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | ||
| Accounts And Other Receivables Net Current |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$165.9M | -$210.1M | -$25.4M | -$449.6M | -$540.2M | -$179.0M | $364.2M | $60.6M | -$210.0M | -$154.4M | -$4.6M | -$186.3M | -$158.7M | -$84.4M | -$89.7M | -$159.0M | $25.0M |
| Investing Cash Flow * | -$446.7M | -$470.5M | -$660.1M | -$348.2M | -$120.4M | -$203.8M | -$864.4M | -$245.5M | -$109.0M | -$66.6M | -$277.9M | -$118.8M | -$59.7M | -$49.9M | -$49.6M | -$50.5M | -$26.1M |
| Operating Cash Flow * | $802.8M | $914.2M | $607.6M | $757.2M | $786.9M | $451.2M | $304.0M | $308.5M | $382.5M | $260.4M | $179.5M | $322.8M | $109.3M | $387.2M | $147.2M | $183.1M | -$45.2M |
| Share Based Compensation | $23.0M | $28.2M | $15.7M | $9.0M | $18.0M | $10.3M | $12.5M | $11.1M | $9.3M | $10.3M | $9.2M | $8.5M | $7.0M | $7.8M | $9.1M | $7.7M | $7.2M |
| Proceeds From Issuance Of Common Stock | $0.00 | $400.0K | $200.0K | $300.0K | $100.0K | $0.00 | $0.00 | $200.0K | $300.0K | $2.1M | $4.1M | $29.3M | $26.3M | $11.0M | $4.9M | $10.1M | $100.0K |
| Payments To Acquire Property Plant And Equipment | $422.2M | $449.3M | $591.3M | $257.8M | $110.7M | $193.8M | $317.5M | $210.2M | $101.9M | $73.2M | $276.2M | $115.4M | $61.1M | $35.8M | $50.3M | $50.5M | $26.1M |
| Payments Of Dividends Common Stock | $0.00 | $0.00 | $129.6M | $129.6M | $174.1M | $158.6M | $172.1M | $177.5M | $176.8M | $246.5M | $390.1M | $199.1M | $188.5M | $166.4M | $34.6M | ||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $40.6M | $21.5M | $12.3M | $5.7M | $14.2M | $2.6M | $1.7M | $2.8M | $2.1M | $3.9M | -$9.2M | -$3.5M | -$8.8M | -$19.2M | -$6.3M | $48.1M | -$5.7M |
| Increase Decrease In Other Accrued Liabilities | $61.8M | $61.6M | $18.1M | $41.0M | $73.0M | $30.9M | $15.5M | $47.8M | $17.7M | $17.8M | $11.6M | $13.1M | $2.4M | -$24.2M | -$37.1M | $47.6M | $900.0K |
| Increase Decrease In Inventories | $15.7M | -$3.4M | $70.8M | $64.3M | -$98.7M | -$3.2M | $28.6M | $51.7M | $9.7M | -$16.2M | $38.5M | $22.1M | -$8.0M | $26.7M | $8.1M | $12.2M | -$40.3M |
| Increase Decrease In Accounts And Other Receivables | $28.9M | $19.7M | -$32.1M | $70.9M | -$46.4M | $118.6M | $18.1M | $2.0M | $28.4M | $39.9M | $5.1M | -$4.9M | $10.6M | -$2.2M | -$24.9M | $30.1M | -$6.6M |
| Depreciation Depletion And Amortization | $216.2M | $185.0M | $172.6M | $161.8M | $135.0M | $131.5M | $119.4M | $92.0M | $83.2M | $79.8M | $70.9M | $61.4M | $61.2M | $65.2M | $62.9M | $61.7M | $56.4M |
| Increase Decrease In Insurance Receivable Asbestos | -$3.9M | -$5.6M | -$6.2M | -$8.3M | -$5.8M | -$7.6M | -$4.8M | -$7.3M | -$93.3M | -$17.2M | -$29.1M | -$25.7M | -$36.8M | -$25.0M | -$22.9M | -$14.4M | |
| Proceeds From Sale Of Property Plant And Equipment | $400.0K | $4.2M | $14.1M | $0.00 | $1.6M | $8.0M | $0.00 | $7.9M | $0.00 | $10.4M | $700.0K | $1.4M | $300.0K | $700.0K | |||
| Effect Of Exchange Rate On Cash And Cash Equivalents | $6.3M | -$6.2M | $6.6M | -$3.2M | $200.0K | $700.0K | $2.5M | -$3.9M | -$2.6M | -$6.1M | -$8.5M | $3.2M | $53.3M | ||||
| Payments Of Debt Issuance Costs | $0.00 | $1.2M | $0.00 | $2.1M | $0.00 | $0.00 | $6.1M | $15.7M | $1.7M | $3.1M | $8.3M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 430.8M | 438.4M | 445.1M | 444.9M | 443.7M | 442.6M | 441.9M | 441.2M | 442.7M | 445.3M | 445.0M | 442.6M | 439.2M | 436.2M | 435.6M | 433.1M | 432.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 432.1M | 439.6M | 445.6M | 445.9M | 445.4M | 444.1M | 443.0M | 442.3M | 443.9M | 447.2M | 446.4M | 444.6M | 440.6M | 437.9M | 435.6M | 433.1M | 434.5M |
| Earnings Per Share Diluted | $0.98 | $1.16 | $1.15 | $1.03 | $0.59 | $0.54 | $0.52 | $0.33 | $0.62 | $0.55 | $0.65 | $0.22 | $0.10 | $1.38 | $-0.80 | $-0.20 | $0.31 |
| Earnings Per Share Basic | $0.98 | $1.16 | $1.15 | $1.03 | $0.59 | $0.55 | $0.52 | $0.33 | $0.62 | $0.55 | $0.65 | $0.22 | $0.10 | $1.39 | $-0.80 | $-0.20 | $0.32 |
| Common Stock Shares Issued | 429.8M | 433.8M | 442.1M | 445.3M | 444.3M | 443.1M | 442.3M | 441.5M | 440.8M | 445.6M | 445.7M | 445.0M | 441.6M | 437.2M | 436.4M | 434.5M | |
| Common Stock Shares Authorized | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | 2.00B | |
| Common Stock Par Or Stated Value Per Share | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 | $0.59 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payment To Fund | $99.2M | $91.8M | $109.6M | $248.5M | $153.3M | $108.9M | $103.0M | $135.1M | $91.1M | $62.8M | $113.0M | $184.1M | $51.5M | $63.7M | |||
| Asbestos Adjustments | $137.6M | $151.7M | $37.0M | $131.7M | $143.9M | $58.2M | $22.0M | $156.4M | $56.8M | -$5.5M | -$33.4M | $195.8M | $117.1M | $15.8M | $85.8M | $224.2M | -$17.4M |
| Interest Paid Net | $63.6M | $41.8M | $41.0M | $37.0M | $56.4M | $61.5M | $57.0M | $26.3M | $26.2M | $20.5M | $4.6M | $100.0K | $11.2M | $9.1M | $7.4M | $7.8M | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $23.3M | $9.6M | $6.2M | $18.0M | $10.3M | $12.5M | $11.1M | $9.3M | $10.3M | $9.2M | $8.5M | $7.0M | $7.8M | $9.1M | $7.7M | $7.2M | |
| Product Warranty Accrual Noncurrent | $26.9M | $28.9M | $30.2M | $31.0M | $33.6M | $35.4M | $39.8M | $45.5M | $37.2M | $33.1M | $26.3M | $23.7M | $20.5M | $19.6M | $20.1M | $18.2M | |
| Product Warranty Accrual Classified Current | $7.3M | $7.3M | $5.4M | $6.7M | $6.0M | $7.0M | $6.8M | $7.3M | $9.4M | $12.2M | $8.9M | $7.7M | $6.6M | $7.4M | $6.1M | $6.7M | |
| Investment Income Interest | $3.1M | $4.1M | $3.4M | $1.0M | $1.0M | $2.3M | $3.4M | $7.9M | $3.8M | $4.6M | $3.7M | $8.2M | |||||
| Interest Paid Capitalized | $21.0M | $19.5M | $8.5M | $1.9M | $9.5M | $9.5M | $5.4M | $4.8M | $2.0M | $3.2M | $1.7M | ||||||
| Stock Issued During Period Value Stock Options Exercised | $200.0K | $300.0K | $2.1M | $4.1M | $29.3M | $26.3M | $11.0M | $4.9M | $10.1M | $100.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q4 2017 |
|---|---|
| Payment To Fund | |
| Asbestos Adjustments | $43.6M |
| Interest Paid Net | |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | |
| Product Warranty Accrual Noncurrent | |
| Product Warranty Accrual Classified Current | |
| Investment Income Interest | |
| Interest Paid Capitalized | |
| Stock Issued During Period Value Stock Options Exercised |
Most recent annual filing with the SEC: May 20, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.